You are hired as a Six Sigma Black Belt of a Biotech company. Your company just went through a product recall after critical defects were reported in several product complaints. A preliminary investigation showed that the source of defect is related to common cause variation of the process, also that the current process has a 31% defective rate. Your first assignment consists in evaluating if the company should implement six sigma as a “business strategy” or as a “program”. Answer the following questions:
1. Indicate your process current sigma level (current baseline) and short term CpK, what would be your sigma level and short term CpK goal.
2. Provide your recommended strategy, “six sigma business strategy vs. six sigma program” and provide selection rationale.
3. What selling strategy will you use to get executive management buy-in?